Dr. Daniel P. Petrylak sits down with CURE during Bladder Cancer Awareness Month to discuss key topics for patients with the ...

Need for Targeted Therapy Current treatments for OAB include ... that applied to other studies reported at the same session. Intravesical instillation of a paclitaxel-containing solution led ...

Alternatively, intravenous pembrolizumab has FDA approval for BCG unresponsive NMIBC. Given the convenience for urologists to manage NMIBC with intravesical therapy, with minimization of systemic ...

The randomized, open-label, single-center trial enrolled 63 patients with primary or recurrent NMIBC who had not received prior adjuvant intravesical therapy. Additional inclusion criteria required ...

Persistence has paid off for Abeona Therapeutics and its gene therapy for recessive dystrophic epidermolysis bullosa (RDEB). About a year after the FDA rejected the company's prior approval filing ...

GIZ943, also known as [177Lu] Lu-EVS459, is a radioligand therapy that targets cells that express folate receptor alpha (FRα). The spokesperson said Novartis stopped development “based on an ...

The TAR-200 system offering sustained intravesical gemcitabine release shows favorable response and tolerability in both the CIS and papillary-only subgroups with BCG-unresponsive high-risk NMIBC.

The Food and Drug Administration on Tuesday approved a new treatment for a rare skin condition, teeing up a commercial battle between two cell and gene therapy developers. The agency cleared Abeona ...

Actor Paresh Rawal has said he drank his urine for 15 days to recover from knee pain, making a case for urine therapy, urophagia or urotherapy. During an interview with Lallantop’s Saurabh Dwivedi, he ...

Phase 3 Trial Design The randomized, open-label, single-center trial enrolled 63 patients with primary or recurrent NMIBC who had not received prior adjuvant intravesical therapy. Additional inclusion ...

Key inclusion criteria were: (1) patients pathologically diagnosed with NMIBC after TURBT at our institution and receiving standard BCG intravesical therapy; (2) availability of blood data obtained ...